Your browser doesn't support javascript.
loading
Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.
O'Connor, Owen A; Lue, Jennifer K; Sawas, Ahmed; Amengual, Jennifer E; Deng, Changchun; Kalac, Matko; Falchi, Lorenzo; Marchi, Enrica; Turenne, Ithamar; Lichtenstein, Renee; Rojas, Celeste; Francescone, Mark; Schwartz, Lawrence; Cheng, Bin; Savage, Kerry J; Villa, Diego; Crump, Michael; Prica, Anca; Kukreti, Vishal; Cremers, Serge; Connors, Joseph M; Kuruvilla, John.
Afiliación
  • O'Connor OA; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA. Electronic address: owenoconnor@columbia.edu.
  • Lue JK; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Sawas A; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Amengual JE; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Deng C; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Kalac M; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Falchi L; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Marchi E; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Turenne I; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Lichtenstein R; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Rojas C; Department of Medicine, Center for Lymphoid Malignancies, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Francescone M; Department of Radiology, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Schwartz L; Department of Radiology, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.
  • Cheng B; Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA; Clinical Translational Research Center, Laboratory of Analytical Pharmacology, Columbia University Medical Center-College of Physicians and Surgeons
  • Savage KJ; BC Cancer Agency, Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Villa D; BC Cancer Agency, Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Crump M; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Prica A; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Kukreti V; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Cremers S; Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA; Clinical Translational Research Center, Laboratory of Analytical Pharmacology, Columbia University Medical Center-College of Physicians and Surgeons
  • Connors JM; BC Cancer Agency, Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Kuruvilla J; Princess Margaret Cancer Centre, Toronto, ON, Canada.
Lancet Oncol ; 19(2): 257-266, 2018 02.
Article en En | MEDLINE | ID: mdl-29276022
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Anaplásico de Células Grandes Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Anaplásico de Células Grandes Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido